Pharmaceutical Supply – Acetylcysteine Solution

The contract pertains to the procurement of sterile injectable Acetylcysteine Solution, identified by NSN 6505007822688, to support treatment for acetaminophen overdose and as a mucolytic agent. This is a commercial off-the-shelf pharmaceutical supply arrangement under a subcontract, managed by the Defense Logistics Agency on behalf of the Department of Defense. The product must meet strict sterile and pharmaceutical standards to ensure clinical safety and efficacy in military and Veterans Affairs healthcare settings, with delivery requirements aligned to operational medical readiness needs. The North American Industry Classification System code 325412 indicates the manufacturing category for pharmaceutical preparations, affirming the product's classification as a standardized medicinal item produced by qualified commercial suppliers. The contract was posted on July 15, 2026, and is administered under the procurement identifier SPE2DX25D8022 with delivery order SPE2D926F7367, indicating it is part of a larger logistics cycle involving multiple fulfillment events. Performance is not limited to a specific geographic location, allowing for nationwide or global distribution as needed to support DOD medical facilities. There is no set-aside designation, meaning the contract is open to all qualified vendors regardless of business size or status. The solution will be integrated into existing military pharmaceutical supply chains and must comply with all federal and military pharmaceutical handling, storage, and traceability protocols to ensure uninterrupted availability for acute care scenarios.